Bonnie W. Ramsey

机构：Seattle Children's Hospital, University of Washington, Seattle Children's Hospital, Seattle Children's Research Institute · ORCID：0000-0001-7116-5281

发表论文 268 篇 · 总被引 35226 次 · h-index 83

代表论文

• Cystic Fibrosis (2023 · JAMA · 被引 318)
• A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele (2021 · American Journal of Respiratory and Critical Care Medicine · 被引 311)
• Triple Therapy for Cystic Fibrosis Phe508del –Gating and –Residual Function Genotypes (2021 · New England Journal of Medicine · 被引 283)
• Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials (2025 · The Lancet Respiratory Medicine · 被引 115)
• Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open-label extension study (2023 · European Respiratory Journal · 被引 96)
• Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials (2023 · The Lancet Respiratory Medicine · 被引 74)